Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US.
The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging is correctly labeled as levetiracetam in 0.75% sodium chloride injection 1,000 mg/100 mL.
The pharmaceutical company distributed the batch between Nov. 4 and Nov. 6 to wholesalers, it said, adding that the recall is being taken place under the knowledge of the US Food and Drug Administration.
Dr. Reddy's shares were up 1.3% in recent Thursday trading.
Price: 12.70, Change: +0.17, Percent Change: +1.32
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.